| Identification of MicroRNAs as breast cancer prognosis markers through the cancer genome atlas JTH Chang, F Wang, W Chapin, RS Huang PloS one 11 (12), e0168284, 2016 | 125 | 2016 |
| Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies P Geeleher, Z Zhang, F Wang, RF Gruener, A Nath, G Morrison, S Bhutra, ... Genome research 27 (10), 1743-1751, 2017 | 117 | 2017 |
| High expression of miR-532-5p, a tumor suppressor, leads to better prognosis in ovarian cancer both in vivo and in vitro F Wang, JTH Chang, CJ Kao, RS Huang Molecular Cancer Therapeutics 15 (5), 2016 | 64 | 2016 |
| Accurate and rapid prediction of tuberculosis drug resistance from genome sequence data using traditional machine learning algorithms and CNN X Kuang, F Wang, KM Hernandez, Z Zhang, RL Grossman Scientific reports 12 (1), 2427, 2022 | 59 | 2022 |
| Cancer expression quantitative trait loci (eQTLs) can be determined from heterogeneous tumor gene expression data by modeling variation in tumor purity P Geeleher, A Nath, F Wang, Z Zhang, AN Barbeira, J Fessler, ... Genome biology 19, 1-14, 2018 | 36 | 2018 |
| Predicting response to histone deacetylase inhibitors using high-throughput genomics P Geeleher, A Loboda, D Lenkala, F Wang, B LaCroix, S Karovic, J Wang, ... Journal of the National Cancer Institute 107 (11), djv247, 2015 | 23 | 2015 |
| Discovering drugs to overcome chemoresistance in ovarian cancers based on the cancer genome atlas tumor transcriptome profile F Wang, JTH Chang, Z Zhang, G Morrison, A Nath, S Bhutra, RS Huang Oncotarget 8 (70), 115102, 2017 | 3 | 2017 |
| Most expression quantitative trait loci discovered in tumors cannot be attributed to cancer cells P Geeleher, F Wang, Z Zhang, RL Grossman, C Seoighe, RS Huang Cancer Research 78 (13_Supplement), 4271-4271, 2018 | | 2018 |
| IDWAS: Imputing drug response in large cohorts of cancer patients to discover novel predictive biomarkers P Geeleher, Z Zhang, F Wang, A Nath, S Bhutra, R Grossman, RS Huang Cancer Research 77 (13_Supplement), 5035-5035, 2017 | | 2017 |
| Imputation of drug sensitivity levels in The Cancer Genome Atlas using machine learning identifies novel predictors of chemotherapeutic response P Geeleher, RS Huang, F Wang, G Morrison Cancer Research 76 (14_Supplement), 2100-2100, 2016 | | 2016 |
| Exploring the longitudinal transcriptomic landscape of tyrosine kinase inhibitor treatment response in chronic myeloid leukemia patients A Nath, F Wang, D Lenkala, B LaCroix, N Glavin, K Kipping-Johnson, ... Journal of Investigative Medicine 64 (4), 935-936, 2016 | | 2016 |
| POTENTIAL OF TARGETING WEE1 AS THERAPY IN THE MANAGEMENT OF TRIPLE NEGATIVE BREAST CANCER. G Morrison, J Wang, F Wang, P Geeleher, R Huang CLINICAL PHARMACOLOGY & THERAPEUTICS 99, S83-S83, 2016 | | 2016 |
| THE COMPLEXITY AND DYNAMICS OF TUMOR RESPONSE TO VORINOSTAT CAN BE ELUCIDATED BY INTEGRATING MULTIPLE LARGE HIGH-THROUGHPUT DATASETS. P Geeleher, A Loboda, D Lenkala, F Wang, J Wang, M Nebozhyn, ... CLINICAL PHARMACOLOGY & THERAPEUTICS 97, S60-S60, 2015 | | 2015 |
Rong Stephanie HuangUniversity of Minnesotaยืนยันอีเมลแล้วที่ umn.edu